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Lung surfactant protein D (SP-D) binds to Mycobacterium tuberculosis surface lipoarabinomannan and
results in bacterial agglutination, reduced uptake, and inhibition of growth in human macrophages. Here we
show that SP-D limits the intracellular growth of bacilli in macrophages by increasing phagosome-lysosome
fusion but not by generating a respiratory burst.
tuberculosis modulates two major macrophage microbicidal
mechanisms: generation of a respiratory burst and regulation
of phagosome-lysosome (P-L) fusion events.
Recombinant rat SP-D (referred to as SP-D throughout the
paper), produced in CHO cells and purified on a mannoseSepharose matrix (22, 23), was used in the different assays at a
concentration of 0.5 (nonagglutinating for M. tuberculosis)
and/or 5.0 (agglutinating for M. tuberculosis) g/ml. Since
SP-D had been shown to inhibit the intracellular growth of M.
tuberculosis in macrophages, we first determined whether SP-D
had a direct microbicidal effect on M. tuberculosis by performing CFU assays following incubation of the bacilli in the absence or presence of SP-D. No significant effect of SP-D on the
viability of bacteria at either 0.5 or 5.0 g/ml was observed
(n ⫽ 2; data not shown).
SP-D does not induce a respiratory burst during phagocytosis of M. tuberculosis in human macrophages. We next determined whether phagocytosis of M. tuberculosis by human
macrophages in the presence of SP-D would stimulate the
production of reactive oxygen intermediates by using the 2⬘,7⬘dichlorofluorescein (DCF) assay (6). Monocyte-derived macrophages (MDMs) were prepared from healthy human volunteers as described previously (24). MDM monolayers on tissue
culture plates were preincubated with 32 mM DCF (Molecular
Probes) for 30 min at 37°C followed by stimulation with
phorbol myristate acetate (PMA; 1 g/ml), opsonized zymosan
(OZ) particles (multiplicity of infection, 20:1), SP-D, M. tuberculosis (multiplicity of infection, 10:1), or M. tuberculosis plus
SP-D (0.5 and 5.0 g/ml). The fluorescence emitted from
the stimulated cells was monitored every 2 min for 2 h by a
Fluostar32 fluorometer (BMG Lab Technologies). This assay
measures production of H2O2-dependent reactive oxygen intermediates (12). PMA and OZ stimulation of MDMs resulted
in progressively increased fluorescence (Fig. 1), indicating that
the MDMs responded to known soluble and particulate stimuli
of the oxidant burst. In contrast, neither SP-D alone, M. tuberculosis alone, nor M. tuberculosis in the presence of SP-D

Pulmonary surfactant proteins A and D (SP-A and SP-D,
respectively) participate in the lung innate and adaptive immune responses against multiple pathogens through opsonization and agglutination of microorganisms, blockade of receptor-ligand interactions, and/or direct effects on host cells,
particularly macrophages (5, 27). Experiments using mice with
homozygous null alleles for the SP-A or SP-D genes provide
direct evidence in support of these phenomena (11, 13, 17–20).
Both SP-A and SP-D have been implicated in the pathogenesis of tuberculosis. Our work has demonstrated that SP-A
increases the phagocytosis of Mycobacterium tuberculosis by
human macrophages by up-regulating the macrophage mannose receptor (MR) (2, 10) and reduces NADPH oxidase activity in these cells (6). In contrast, SP-D, through its carbohydrate recognition domain (CRD), binds to the terminal
mannose caps of the M. tuberculosis surface lipoglycan lipoarabinomannan (ManLAM) and causes agglutination of the
bacilli and inhibition of bacterial uptake by macrophages (7).
However, the reduced uptake was not dependent on bacterial
agglutination (8). The presence of SP-D also inhibited the
intracellular growth of M. tuberculosis in macrophages (8). M.
tuberculosis evades several host defense mechanisms including
by inhibiting fusion of its own phagosome with lysosomes in
macrophages (1) and avoiding the potential stimulation of
intracellular oxidant production during phagocytosis (26).
We hypothesized that SP-D inhibits the intracellular growth
of M. tuberculosis in macrophages by altering intracellular
events that restrict mycobacterial growth following phagocytosis. In this study, we examined whether SP-D coating of M.
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stimulated detectable levels of oxidants over medium-only control. These data indicate that SP-D does not stimulate a detectable respiratory burst in macrophages during phagocytosis
of M. tuberculosis.
SP-D increases the fusion of M. tuberculosis phagosomes
with lysosomes in human macrophages. Since SP-D binds to
the terminal mannosyl units of ManLAM (7) and ManLAM is
a bacterial determinant that inhibits M. tuberculosis phagosome maturation (9, 14), we hypothesized that binding of SP-D
to the surface of M. tuberculosis would alter the surface characteristics of the bacterium and result in enhanced M. tuberculosis phagosome maturation. In order to test this hypothesis,
we performed complementary transmission electron microscopy (TEM) and confocal microscopy assays to assess P-L
fusion in M. tuberculosis-infected MDMs. The TEM assay relies on the labeling of lysosomes and late endosomes with
horseradish peroxidase (HRP) and the subsequent visualization of these compartments in the form of a black precipitate
within or separate from phagosomes following the addition of
diaminobenzidine (14, 16). In the absence of HRP, there is no
formation of black precipitate (data not shown). M. tuberculosis strain Erdman (ATCC 35801) was preincubated with SP-D
for 1 h at 4°C before infection of the HRP-loaded MDM
monolayers for 2 h at 37°C. Black precipitate within the M.
tuberculosis phagosome was scored as P-L fusion. In the presence of SP-D, M. tuberculosis phagosomes demonstrated increased P-L fusion compared to the control phagosomes (Fig.
2). We found that SP-D caused relatively higher P-L fusion for
phagosomes that contain single bacilli than for phagosomes
containing two or more bacilli (58.2% ⫾ 5.2% with SP-D
versus 38.1% ⫾ 2.6% without SP-D) (Fig. 2C). As the number
of bacilli per phagosome increased (whether single or

clumped), so did P-L fusion—an effect that was further enhanced in the presence of SP-D, except in the case of phagosomes each with three or more bacilli where the percentage of
P-L fusion was very high. These data indicate that SP-D coating of M. tuberculosis has a direct effect on increasing P-L
fusion of single bacilli and also may have an indirect effect by
inducing agglutination of the phagocytosed bacilli to a certain
extent.
The confocal microscopy assay for P-L fusion is based on
colocalization of the phagosomes with the lysosomal/late endosomal markers LAMP-1 and/or CD63 as described previously (14, 21). A green fluorescent protein-expressing M. tuberculosis H37Rv strain (M. tuberculosis-GFP; a kind gift from
V. Deretic, University of New Mexico) was preincubated with
SP-D before infection of the MDM monolayers as described
above. The yellow appearance of individual bacilli on confocal
images represents a colocalization of the bacillus (green) with
the lysosomal marker (red). The association of M. tuberculosis
phagosomes with LAMP-1 was significantly increased from
33.3% ⫾ 1.5% (control) to 53.5% ⫾ 5.5% in the presence of
SP-D (Fig. 3). In separate experiments, we found that SP-D
also increased the colocalization of M. tuberculosis-GFP with
CD63 (Fig. 3). These data correlate well with our TEM data
and together with them provide strong evidence that SP-D
enhances P-L fusion of M. tuberculosis-containing phagosomes.
ManLAM beads are phagocytosed by the macrophage MR
and reside in phagosomes with limited P-L fusion (14). To
determine whether the effect on SP-D of increasing the P-L
fusion of M. tuberculosis-containing phagosomes was related to
its binding to ManLAM and disrupting the ManLAM-MR
pathway, we assayed for P-L fusion of ManLAM beads or
control human serum albumin (HSA) beads in the presence or
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FIG. 1. SP-D does not induce a respiratory burst in human macrophages. MDM monolayers in triplicate tissue culture wells were loaded with
DCF and then stimulated with PMA, OZ, M. tuberculosis, SP-D (0.5 or 5.0 g/ml), SP-D plus M. tuberculosis, or medium control. The fluorescence
of each well was determined every 2 minutes for 120 min and expressed in relative fluorescence units. Shown are the means of triplicate
determinations in one experiment representative of three.
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absence of SP-D. Purified ManLAM from M. tuberculosis H37Rv
was used to coat green fluorescent polystyrene beads (Polysciences, Inc.) as described previously (25), and the ManLAMcoated beads or HSA control beads were preincubated with
SP-D before they were added to the MDM monolayers as done
above with M. tuberculosis. The cells were processed (14) and
analyzed by confocal microscopy. The yellow color obtained by
colocalization of the green beads with the red-stained CD63
marker was scored as P-L fusion. In the absence of SP-D, P-L

fusion for ManLAM bead phagosomes was 34% ⫾ 2%,
whereas in the presence of SP-D, there was a significant increase in P-L fusion (56% ⫾ 2%, mean ⫾ standard error of the
mean [SEM]; n ⫽ 2; P ⬍ 0.05). In contrast, there was no
significant difference in the level of P-L fusion with or without
SP-D treatment for HSA control beads (data not shown).
To determine whether the increased P-L fusion seen with M.
tuberculosis and SP-D is due primarily to bacterial agglutination which requires the collagen-like region (CLR) of SP-D
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FIG. 2. SP-D increases P-L fusion of M. tuberculosis-containing phagosomes. Duplicate MDM monolayers were loaded with HRP and then
incubated with M. tuberculosis in the presence or absence of SP-D. After 2 h at 37°C, the MDMs were fixed and the HRP revealed by
diaminobenzidine. The MDMs were then processed for TEM. (A) TEM section showing a single bacillus contained in a phagosome that has not
fused with lysosomes. (B) TEM section showing a single bacillus (arrowhead) contained within a phagosome that also contains the characteristic
black HRP precipitate (arrow), indicating P-L fusion. (C) Graph showing the summary of percentages of M. tuberculosis phagosomes containing
the HRP precipitate with one, two, or three or more bacilli per phagosome. The results shown are the means ⫾ standard deviations of duplicate
determinations in a representative experiment (mean ⫾ standard deviation, n ⫽ 2, P ⬍ 0.05 for the SP-D group versus the control group for one
or two bacteria).
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(8), we performed similar experiments with M. tuberculosis
using the trimeric neck CRD (NCRD) fusion protein, which
lacks the CLR but contains the neck and CRD of human SP-D
(4). We found that the NCRD protein also increased P-L
fusion for M. tuberculosis-containing phagosomes (Fig. 4).
These data indicate that the increased P-L fusion due to SP-D
does not require the CLR of the protein or agglutination of the
bacilli. These data, along with our previous work (7, 8), provide
further evidence that SP-D influences the interaction between
the macrophage and M. tuberculosis primarily via the CRD
portion of the protein that binds to the surface of the bacterium via ManLAM.
SP-D is an important member of the lung collectin family.
Lung collectins are involved in the pathogenesis and host defense of many respiratory infectious diseases including tuberculosis. SP-D has been shown to reduce entry of M. tuberculosis
into macrophages, agglutinate the bacteria potentially to aid
their clearance from the lung, and reduce survival of the SPD-coated bacilli that are phagocytosed by macrophages. In the
current study, we provide a potential mechanism for the reduced intracellular survival of M. tuberculosis in macrophages,
i.e., SP-D enhances fusion of the M. tuberculosis phagosome
with lysosomes. M. tuberculosis ManLAM has been shown to
be a key molecule in mediating phagosome maturation arrest
(3, 9). We have previously demonstrated that the CRD of
SP-D binds to the terminal mannose caps of ManLAM (7). At

FIG. 4. NCRD increases the colocalization of M. tuberculosis-GFP
with LAMP-1. M. tuberculosis-GFP bacteria were incubated with or
without SP-D or NCRD (5.0 g/ml) for 1 h, added to MDM monolayers for 2 h, fixed, and then sequentially incubated with antibodies to
LAMP-1 and Texas Red anti-mouse immunoglobulin G. The MDM
monolayers were then examined by confocal microscopy. The graph
shows the percentages of P-L fusion of single M. tuberculosis bacilli in
the absence or presence of human SP-D or its derivative NCRD.
Shown are the means ⫾ SEMs of triplicate determinations from three
independent experiments (mean ⫾ SEM, n ⫽ 3, P ⬍ 0.05, for the SP-D
and NCRD groups versus the control group).
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FIG. 3. SP-D increases the colocalization of M. tuberculosis with lysosomal markers LAMP-1 and CD63. M. tuberculosis-GFP bacteria were
incubated with or without SP-D (5.0 g/ml) for 1 h, added to MDM monolayers for 2 h at 37°C, fixed, and then sequentially incubated with
antibodies to LAMP-1 or CD63 and Texas Red anti-mouse immunoglobulin G. The MDM monolayers were then examined by confocal
microscopy. The graph illustrates the percentages of single M. tuberculosis-GFP bacilli that colocalize with LAMP-1 or CD63, representing P-L
fusion. The inset shows confocal micrographs of unfused (green on upper panel) and fused (yellow on lower panel) M. tuberculosis in phagosomes.
Data shown are the means ⫾ SEMs of triplicate determinations from three independent experiments (mean ⫾ SEM, n ⫽ 3, P ⬍ 0.05, for the SP-D
group versus the control group).
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the same time, the macrophage MR recognizes the terminal
mannose caps of ManLAM as its principal ligand in mediating
phagocytosis of virulent M. tuberculosis by human macrophages (15, 24, 25). Therefore, the reduced phagocytosis of M.
tuberculosis in the presence of SP-D observed in our previous
study (7) is likely due to a reduction in the interaction between
the ManLAM caps and the MR. Recently, we have demonstrated that the MR plays a crucial role in inhibiting maturation of phagosomes containing M. tuberculosis or ManLAMcoated beads (14). Blocking the MR activity by specific
inhibitors or masking the ManLAM mannose caps by antiManLAM antibody redirected the particles toward other
phagocytic receptors and caused higher levels of P-L fusion in
macrophages (14).
Taken together, our current study clearly supports the idea
that SP-D binds and masks the terminal mannose caps of
ManLAM on the surface of M. tuberculosis and directs phagocytosis of the bacilli through alternative routes other than the
ManLAM-MR pathway, thereby promoting phagosome maturation. Thus, our data indicate that SP-D, in contrast to SP-A,
serves as an important innate host defense protein for M.
tuberculosis in the lungs.
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